Mental disorders and mortality in cancer survivors: Key unaddressed factors

IF 5.6 2区 医学 Q1 ONCOLOGY Cancer Pub Date : 2025-04-07 DOI:10.1002/cncr.35837
Sheng Li MD, Zuyin Ge MD
{"title":"Mental disorders and mortality in cancer survivors: Key unaddressed factors","authors":"Sheng Li MD,&nbsp;Zuyin Ge MD","doi":"10.1002/cncr.35837","DOIUrl":null,"url":null,"abstract":"<p>We were very interested in reading the study by Mai et al.,<span><sup>1</sup></span> which provides important data on the association between mental disorders and mortality in cancer survivors. However, there are some potential flaws in the study that have not been fully explored and are worth further analysis and improvement.</p><p>First, the data for this study were collected from patients who had cancer between 2009 and 2015 and included a follow-up period of 5 years to assess the incidence of mental disorders and their association with mortality outcomes in 2021. We noted that the mortality data collection in 2021 occurred during the coronavirus disease 2019 pandemic, but the study did not consider the possible impact of the pandemic on the mental health of cancer survivors. During the pandemic, health care resources were reallocated globally, and patients may have faced delays in treatment, increased psychological stress, and a decline in quality of life, all of which had a profound impact on mental health.<span><sup>2</sup></span> The cancer survivors mentioned in the study were more likely to experience mental health symptoms, such as stress, anxiety, depression, loneliness, and hopelessness, especially young adults, adults without a high school diploma, women, and survivors with limited social support.<span><sup>3</sup></span> Therefore, the failure to consider the impact of coronavirus disease 2019 may introduce bias into the study, particularly regarding the relationship between mental disorders and mortality during the pandemic. Future research should take into account these specific factors during the pandemic and assess their potential effects on the mental health and mortality of cancer survivors, especially the long-term exacerbation of mental disorders.</p><p>Second, data from Mai Tran et al.<span><sup>1</sup></span> indicate that the incidence of mental disorders is significantly higher in female cancer survivors compared with males. The rates of depression and anxiety in women are 12% and 15%, respectively, whereas the corresponding rates for men are 8% and 10%, respectively. However, although the data indicate higher rates of mental disorders in women, the study does not thoroughly explore the underlying causes of this sex difference. Sex differences in mental health are multifaceted and may be closely related to physiologic factors, psychological stress, social roles, and sex-specific differences in cancer treatment. Women may face more psychological challenges related to body image, gender roles, and hormonal fluctuations during cancer treatment,<span><sup>4</sup></span> but these differences are not adequately addressed in the study. In addition, female patients may face greater social support and economic pressures after cancer treatment, factors that can worsen mental health issues. Future research should delve deeper into the causes of these differences and explore the biologic and sociologic mechanisms behind mental disorder development in female cancer survivors, ultimately leading to personalized psychological interventions.</p><p>Moreover, the study focuses on the association between a single type of mental disorder and mortality but does not examine the impact of comorbid mental disorders on mortality. In reality, cancer survivors may have multiple mental disorders simultaneously,<span><sup>5</sup></span> and literature and clinical evidence suggest that comorbid mental disorders increase the pathologic burden, lower treatment adherence, and elevate the risk of suicide.<span><sup>5</sup></span> The physical and psychological burden on patients with comorbid conditions is more complex, and the impact on mortality is not simply the additive effect of individual disorders. The failure to investigate this aspect may result in an incomplete assessment of how mental disorders affect mortality. We recommend that the authors conduct subgroup analyses to compare patients who have comorbidities with those who have a single mental disorder, assess the additional risks of comorbidity, or introduce multivariable models to explore how interactions between different mental disorders affect mortality in cancer survivors.</p><p>By strengthening the exploration of these aspects in future research, we can provide a more comprehensive evidence base for managing the mental health of cancer survivors and offer more precise guidance for public health policies and personalized treatment strategies.</p><p>The authors declared no conflicts of interest.</p>","PeriodicalId":138,"journal":{"name":"Cancer","volume":"131 8","pages":""},"PeriodicalIF":5.6000,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cncr.35837","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cncr.35837","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

We were very interested in reading the study by Mai et al.,1 which provides important data on the association between mental disorders and mortality in cancer survivors. However, there are some potential flaws in the study that have not been fully explored and are worth further analysis and improvement.

First, the data for this study were collected from patients who had cancer between 2009 and 2015 and included a follow-up period of 5 years to assess the incidence of mental disorders and their association with mortality outcomes in 2021. We noted that the mortality data collection in 2021 occurred during the coronavirus disease 2019 pandemic, but the study did not consider the possible impact of the pandemic on the mental health of cancer survivors. During the pandemic, health care resources were reallocated globally, and patients may have faced delays in treatment, increased psychological stress, and a decline in quality of life, all of which had a profound impact on mental health.2 The cancer survivors mentioned in the study were more likely to experience mental health symptoms, such as stress, anxiety, depression, loneliness, and hopelessness, especially young adults, adults without a high school diploma, women, and survivors with limited social support.3 Therefore, the failure to consider the impact of coronavirus disease 2019 may introduce bias into the study, particularly regarding the relationship between mental disorders and mortality during the pandemic. Future research should take into account these specific factors during the pandemic and assess their potential effects on the mental health and mortality of cancer survivors, especially the long-term exacerbation of mental disorders.

Second, data from Mai Tran et al.1 indicate that the incidence of mental disorders is significantly higher in female cancer survivors compared with males. The rates of depression and anxiety in women are 12% and 15%, respectively, whereas the corresponding rates for men are 8% and 10%, respectively. However, although the data indicate higher rates of mental disorders in women, the study does not thoroughly explore the underlying causes of this sex difference. Sex differences in mental health are multifaceted and may be closely related to physiologic factors, psychological stress, social roles, and sex-specific differences in cancer treatment. Women may face more psychological challenges related to body image, gender roles, and hormonal fluctuations during cancer treatment,4 but these differences are not adequately addressed in the study. In addition, female patients may face greater social support and economic pressures after cancer treatment, factors that can worsen mental health issues. Future research should delve deeper into the causes of these differences and explore the biologic and sociologic mechanisms behind mental disorder development in female cancer survivors, ultimately leading to personalized psychological interventions.

Moreover, the study focuses on the association between a single type of mental disorder and mortality but does not examine the impact of comorbid mental disorders on mortality. In reality, cancer survivors may have multiple mental disorders simultaneously,5 and literature and clinical evidence suggest that comorbid mental disorders increase the pathologic burden, lower treatment adherence, and elevate the risk of suicide.5 The physical and psychological burden on patients with comorbid conditions is more complex, and the impact on mortality is not simply the additive effect of individual disorders. The failure to investigate this aspect may result in an incomplete assessment of how mental disorders affect mortality. We recommend that the authors conduct subgroup analyses to compare patients who have comorbidities with those who have a single mental disorder, assess the additional risks of comorbidity, or introduce multivariable models to explore how interactions between different mental disorders affect mortality in cancer survivors.

By strengthening the exploration of these aspects in future research, we can provide a more comprehensive evidence base for managing the mental health of cancer survivors and offer more precise guidance for public health policies and personalized treatment strategies.

The authors declared no conflicts of interest.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
癌症幸存者的精神障碍和死亡率:未解决的关键因素
我们对Mai等人的研究非常感兴趣,它提供了癌症幸存者中精神障碍和死亡率之间关系的重要数据。然而,研究中也存在一些潜在的缺陷,没有被充分挖掘,值得进一步分析和改进。首先,本研究的数据是从2009年至2015年期间患有癌症的患者中收集的,并包括5年的随访期,以评估精神障碍的发病率及其与2021年死亡结果的关系。我们注意到,2021年的死亡率数据收集发生在2019年冠状病毒病大流行期间,但该研究没有考虑大流行对癌症幸存者心理健康的可能影响。在大流行期间,全球重新分配了卫生保健资源,患者可能面临治疗延误、心理压力增加和生活质量下降,所有这些都对心理健康产生了深远影响研究中提到的癌症幸存者更有可能经历心理健康症状,如压力、焦虑、抑郁、孤独和绝望,尤其是年轻人、没有高中文凭的成年人、女性和社会支持有限的幸存者因此,未能考虑2019冠状病毒病的影响可能会给研究带来偏见,特别是在大流行期间精神障碍与死亡率之间的关系方面。未来的研究应考虑到大流行期间的这些具体因素,并评估它们对癌症幸存者的心理健康和死亡率的潜在影响,特别是精神障碍的长期恶化。其次,Mai Tran等人1的数据表明,女性癌症幸存者的精神障碍发生率明显高于男性。女性的抑郁和焦虑比例分别为12%和15%,而男性的相应比例分别为8%和10%。然而,尽管数据表明女性患精神疾病的比例更高,但这项研究并没有彻底探讨这种性别差异的潜在原因。心理健康方面的性别差异是多方面的,可能与生理因素、心理压力、社会角色和癌症治疗中的性别差异密切相关。在癌症治疗期间,女性可能会面临更多与身体形象、性别角色和荷尔蒙波动有关的心理挑战,但这些差异在研究中没有得到充分解决。此外,女性患者在癌症治疗后可能面临更大的社会支持和经济压力,这些因素可能会恶化心理健康问题。未来的研究应深入研究这些差异的原因,并探索女性癌症幸存者精神障碍发展背后的生物学和社会学机制,最终导致个性化的心理干预。此外,该研究侧重于单一类型的精神障碍与死亡率之间的关系,但没有检查共病性精神障碍对死亡率的影响。实际上,癌症幸存者可能同时患有多种精神障碍,文献和临床证据表明,共病性精神障碍增加了病理负担,降低了治疗依从性,并增加了自杀的风险伴随疾病的患者的生理和心理负担更为复杂,对死亡率的影响不仅仅是个体疾病的叠加效应。未能对这方面进行调查可能导致对精神障碍如何影响死亡率的评估不完整。我们建议作者进行亚组分析,比较有合并症的患者与有单一精神障碍的患者,评估合并症的额外风险,或引入多变量模型,探索不同精神障碍之间的相互作用如何影响癌症幸存者的死亡率。通过在未来的研究中加强这些方面的探索,我们可以为癌症幸存者的心理健康管理提供更全面的证据基础,并为公共卫生政策和个性化治疗策略提供更精确的指导。作者声明没有利益冲突。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer
Cancer 医学-肿瘤学
CiteScore
13.10
自引率
3.20%
发文量
480
审稿时长
2-3 weeks
期刊介绍: The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society. CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines: blood/bone marrow; breast disease; endocrine disorders; epidemiology; gastrointestinal tract; genitourinary disease; gynecologic oncology; head and neck disease; hepatobiliary tract; integrated medicine; lung disease; medical oncology; neuro-oncology; pathology radiation oncology; translational research
期刊最新文献
Outcomes of loncastuximab tesirine in heavily pretreated patients with diffuse large B-cell lymphoma, including the post-CAR T-cell therapy setting: A meta-analysis. Vobramitamab duocarmazine, an anti-B7-H3 antibody-drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion. 36 is the new 18: Functional high-risk multiple myeloma in the modern era. The impact of whole lung irradiation in lung metastatic rhabdomyosarcoma: A pooled analysis of two European trials and one European registry. HER2-targeting zongertinib shows early activity in untreated advanced HER2-mutant NSCLC.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1